Literature DB >> 1790639

Liver scan abnormalities in polymyalgia rheumatica/giant cell arteritis.

V Kyle1, E P Wraight, B L Hazleman.   

Abstract

Liver involvement in polymyalgia rheumatica/giant cell arteritis (PMR/GCA) before treatment and during follow-up of up to 3 1/2 years was assessed in 74 patients clinically, with liver function tests, isotope scans and blood flow studies. Twenty-seven patients had elevated alkaline phosphatase levels which fell to normal after 2.6 weeks treatment. Both PMR and GCA patients were affected, the latter more commonly. Isotope scans were abnormal in 7 of 29 patients and remained abnormal on follow-up. The arterial fraction of hepatic flow was significantly reduced in GCA patients in comparison with those having PMR only; values became normal after treatment. These abnormalities may be due to hepatic arteritis.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1790639     DOI: 10.1007/bf02208693

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  21 in total

1.  Arteritis of the aged (giant cell arteritis) and fever of unexplained origin.

Authors:  M K Ghose; S Shensa; P I Lerner
Journal:  Am J Med       Date:  1976-03       Impact factor: 4.965

2.  Polymyalgia rheumatica and liver disease.

Authors:  R Long; O James
Journal:  Lancet       Date:  1974-01-19       Impact factor: 79.321

3.  Observations on temporal arteritis.

Authors:  B Wadman; I Werner
Journal:  Acta Med Scand       Date:  1972-11

4.  Giant-cell arteritis and raised serum-alkaline-phosphatase levels.

Authors:  G H Hall; T Hargreaves
Journal:  Lancet       Date:  1972-07-01       Impact factor: 79.321

5.  Significance of antimitochondrial antibodies.

Authors: 
Journal:  Lancet       Date:  1981 Dec 19-26       Impact factor: 79.321

6.  Polymyalgia rheumatica and primary biliary cirrhosis.

Authors:  J C Robertson; G F Batstone; W Y Loebl
Journal:  Br Med J       Date:  1978-10-21

7.  Granulomatous liver disease and giant cell arteritis. Case report and literature review.

Authors:  K D Litwack; A Bohan; L Silverman
Journal:  J Rheumatol       Date:  1977       Impact factor: 4.666

8.  Liver involvement in polymyalgia rheumatica.

Authors:  J von Knorring; C Wassatjerna
Journal:  Scand J Rheumatol       Date:  1976       Impact factor: 3.641

9.  Polymyalgia rheumatica: a 10-year epidemiologic and clinical study.

Authors:  T Y Chuang; G G Hunder; D M Ilstrup; L T Kurland
Journal:  Ann Intern Med       Date:  1982-11       Impact factor: 25.391

10.  Hepatocellular disease in the giant-cell arteritis/polymyalgia rheumatica syndrome.

Authors:  A S Leong; M H Alp
Journal:  Ann Rheum Dis       Date:  1981-02       Impact factor: 19.103

View more
  5 in total

1.  Polymyalgia rheumatica: pitfalls in diagnosis.

Authors:  S Siebert; T M Lawson; M H Wheeler; J C Martin; B D Williams
Journal:  J R Soc Med       Date:  2001-05       Impact factor: 5.344

2.  Fevers, headache and abnormal liver function in a 68-year-old man.

Authors:  Jonathan M R Goulding; A Pitcher; J Piris; C P Conlon
Journal:  J R Soc Med       Date:  2010-06-03       Impact factor: 5.344

Review 3.  Giant cell arteritis and polymyalgia rheumatica: pathophysiology and management.

Authors:  Miguel A Gonzalez-Gay; Carlos Garcia-Porrua; Jose A Miranda-Filloy; Javier Martin
Journal:  Drugs Aging       Date:  2006       Impact factor: 3.923

Review 4.  Clinical features of polymyalgia rheumatica and giant cell arteritis.

Authors:  Carlo Salvarani; Nicolò Pipitone; Annibale Versari; Gene G Hunder
Journal:  Nat Rev Rheumatol       Date:  2012-07-24       Impact factor: 20.543

5.  Liver involvement in polymyalgia rheumatica and giant cell arteritis.

Authors:  Elvis Hysa; Alberto Castagna; Ciro Manzo
Journal:  Reumatologia       Date:  2020-12-23
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.